Supplementary Table S1. AIC/BIC of parametric function fitting for OS, PFS and ToT Supplementary Table S2. AE related hospitalization costs (2021 USD)

DataCite Commons2024-05-16 更新60

Additional file 1 of Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer

乳腺癌药物经济学

免疫治疗成本效益

Supplementary Material 1

DataCite Commons2024-08-18 更新40

Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer

乳腺癌药物经济学

靶向治疗疗效

Objectives Adjuvant paclitaxel and trastuzumab has been shown to be an effective regimen with low risk of cancer recurrence and treatment-related toxicities in early-stage node-negative, HER2-positive

NIAID Data Ecosystem30